 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
* v3 b/ D( \7 ~, V! F; u- m# p8 t) H & V9 p' u# _! \+ f3 G* c
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
3 |- o5 R9 F6 w- {/ U8 _ ( I6 [4 j6 `3 J- b
BY THE EDMONTON JOURNAL FEBRUARY 16, 20078 i+ d- S" u/ |, t$ b% r9 F
9 o4 } t2 R1 d c4 ]) {: _2 _4 {5 [
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.& F- ]6 I1 ^, P7 d* _+ ~
* i6 @& M# \0 ~
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM.": M }! F: @) v, G
; N. c+ t& e2 t1 z0 V
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.- u& d% ^. n: o! b' y! Q& W3 W; }5 |
1 K" c) K9 v$ m$ I
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
$ R& \) c* v- T. H; P! F& N) N; y; p+ D+ ^ r
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
9 y, v9 p9 E( r9 q3 n% o) J) J3 G
"As a scientist, it's one of the highlights of my CAREER," Shan said.
6 _% X- c" T& s8 `) J, T, @# Y7 K0 I; U; {- _
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
; P: q* W+ b9 o$ c7 q6 L. ]
+ F( H3 F" i( N a% O/ vIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
! D/ A7 r; w9 ~; k6 T1 ]+ Y) T
$ |& e; I; r. K- m) rGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.+ ^: h- h8 b" \- v4 D5 l& ~
# n6 o# k: t& z7 G k4 e
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
7 X& o6 v+ ~ S0 u' Z- {: k
. i* v3 z( ^1 k. G* g) j% [ x5 r; A% |3 p: [3 S$ n
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|